HopeStage
Back to all studies
RecruitingNCT07278505

Cannabidiol and stress responses after early-life adversity

About this titleRead the official source — NCT07278505
Medication studyAges 18–25United StatesAnxiety
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 25 years.

What will I do during this study?

You are randomly assigned to oral cannabidiol (CBD) or inactive placebo. The study examines stress responses and brain measures in a laboratory setting. The registry lists a 400 mg CBD dose but the reviewed fields do not describe the visit schedule.

Listed locations
New YorkSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 29, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
160
Sponsor
Icahn School of Medicine at Mount Sinai
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
United States
Age range
From 18 Years to 25 Years
Official registry ID
NCT07278505
Official title
Show the full official title

Pathophysiological Mechanisms of Cannabidiol in Stress Regulation

Recruitment & locations

Currently recruiting

New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Icahn School of Medicine at Mount Sinai, a university.

Does this study involve medication?

Yes. The study involves medication, including Cannabidiol and Placebo.

Who can participate?

Listed age limits: 18 years to 25 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies